At the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Hisky Medical drew strong attention with our on-site demonstrations of the iLivTouch® non-invasive liver diagnostic system.
Our booth welcomed a diverse group of healthcare professionals — not only from across the United States, but also from Latin America, Europe, the Middle East, Southeast Asia, and Australia.
Endocrinologists and metabolic specialists showed great interest in Transient Elastography (TE) technology for evaluating liver fibrosis and steatosis, recognizing its growing value in the management of MASLD and related metabolic conditions.
We're proud to see iLivTouch® gaining global recognition as a powerful tool for early liver assessment — bridging the gap between hepatology and endocrinology.
Thank you to everyone who visited us at ADA 2025. Let's continue working together to advance non-invasive liver diagnostics in metabolic health.
